Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.
Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Sünkel U, Walter U, Wirdefeldt K, Berg D. Lerche S, et al. Among authors: oertel w. Neuroepidemiology. 2015;45(4):282-97. doi: 10.1159/000439221. Epub 2015 Nov 3. Neuroepidemiology. 2015. PMID: 26523894
Cabergoline versus levodopa monotherapy: a decision analysis.
Smala AM, Spottke EA, Machat O, Siebert U, Meyer D, Köhne-Volland R, Reuther M, DuChane J, Oertel WH, Berger KB, Dodel RC. Smala AM, et al. Mov Disord. 2003 Aug;18(8):898-905. doi: 10.1002/mds.10465. Mov Disord. 2003. PMID: 12889079
Prevalence and incidence of Parkinson's disease in Europe.
von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. von Campenhausen S, et al. Among authors: oertel w. Eur Neuropsychopharmacol. 2005 Aug;15(4):473-90. doi: 10.1016/j.euroneuro.2005.04.007. Eur Neuropsychopharmacol. 2005. PMID: 15963700 Review.
Cost of illness and its predictors for Parkinson's disease in Germany.
Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R. Spottke AE, et al. Pharmacoeconomics. 2005;23(8):817-36. doi: 10.2165/00019053-200523080-00007. Pharmacoeconomics. 2005. PMID: 16097843
Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ, Poewe W. Scherfler C, et al. Among authors: oertel w. Mov Disord. 2007 Jul 15;22(9):1229-38. doi: 10.1002/mds.21505. Mov Disord. 2007. PMID: 17486648 Review.
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU. Riedel O, et al. Among authors: oertel w. J Neurol. 2008 Feb;255(2):255-64. doi: 10.1007/s00415-008-0720-2. Epub 2008 Jan 22. J Neurol. 2008. PMID: 18204803
868 results